Gui‐Shuang Ying
Penn Presbyterian Medical Center(US)Inner Mongolia University(CN)California University of Pennsylvania(US)Applied Photonics (United Kingdom)(GB)Pennine Care NHS Foundation Trust(GB)Hangzhou Red Cross Hospital(CN)University of Pennsylvania(US)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Retinal Imaging and Analysis, Glaucoma and retinal disorders, Retinopathy of Prematurity Studies, Neonatal Respiratory Health Research
Most-Cited Works
- → Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration(2012)1,702 cited
- → Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial(2009)852 cited
- → Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration(2016)690 cited
- → Diabetic Retinopathy Preferred Practice Pattern®(2019)676 cited
- → Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials(2013)578 cited
- → Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration(2009)551 cited